AR was also shown to be up-regulated in a murine model of NASH and in patients with liver scored for advanced levels of fibrosis and cirrhosis, suggesting that AR may be an important factor in a spectrum of liver diseases ranging from NAFLD trough NASH to cirrhosis. This evidence concerns the gene AR and metabolic dysfunction-associated steatohepatitis.